BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 34944929)

  • 1. p16 overexpression identifies oncogenic high-risk HPV infection in non-oropharyngeal squamous cell carcinoma of the head and neck.
    Becker AS; Merkel J; Bozkurt I; Strüder DF; Maletzki C; Hühns M; Zimpfer AH
    Head Neck; 2024 Apr; ():. PubMed ID: 38594829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinicopathologic characteristics of HPV-associated head and neck squamous cell carcinoma in Southern China: long-term retrospective study of 400 cases.
    Du M; Lin Q; Yan S; Gao X; Yang C; Li Z; Liao W; Yang A; Chen S
    Ther Adv Med Oncol; 2024; 16():17588359241242962. PubMed ID: 38617023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Role of Human Papilloma Virus in Dictating Outcomes in Head and Neck Squamous Cell Carcinoma.
    Brennan S; Baird AM; O'Regan E; Sheils O
    Front Mol Biosci; 2021; 8():677900. PubMed ID: 34250016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Childhood tonsillectomy alters the primary distribution of HPV-related oropharyngeal squamous cell carcinoma.
    Altenhofen B; DeWees TA; Ahn JW; Yeat NC; Goddu S; Chen I; Lewis JS; Thorstad WL; Chole RA; Gay HA
    Laryngoscope Investig Otolaryngol; 2020 Apr; 5(2):210-216. PubMed ID: 32337351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-dose loco-regional pattern of failure after primary radiotherapy in p16 positive and negative head and neck squamous cell carcinoma - A DAHANCA 19 study.
    Kristensen MH; Holm AIS; Hansen CR; Zukauskaite R; Samsøe E; Maare C; Johansen J; Primdahl H; Bratland Å; Kristensen CA; Andersen M; Overgaard J; Eriksen JG
    Clin Transl Radiat Oncol; 2024 May; 46():100772. PubMed ID: 38596816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Case of Peritoneal Carcinomatosis After Hyperprogression in Human Papillomavirus-Positive (HPV+) Oropharyngeal Squamous Cell Carcinoma.
    Bach R; Corbera A; Sumarroca A; Gimeno J; Guix M
    Cureus; 2024 Jun; 16(6):e62509. PubMed ID: 38887752
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent Advances and Future Directions in Clinical Management of Head and Neck Squamous Cell Carcinoma.
    Muzaffar J; Bari S; Kirtane K; Chung CH
    Cancers (Basel); 2021 Jan; 13(2):. PubMed ID: 33477635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of Suppressive Myeloid Cell Enrichment with Aggressive Oropharynx Squamous Cell Carcinoma.
    Yang C; Garg R; Fredenburg K; Weidert F; Mendez-Gomez H; Amdur R; Lee JH; Ku J; Kresak J; Staras S; Sikora AG; Wang L; McGrail D; Mitchell D; Sayour E; Silver N
    Cancers (Basel); 2023 Apr; 15(8):. PubMed ID: 37190274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune and Microbial Signatures Associated with PD-1 Blockade Sensitivity in a Preclinical Model for HPV+ Oropharyngeal Cancer.
    Díaz-Rivera J; Rodríguez-Rivera MA; Meléndez-Vázquez NM; Godoy-Vitorino F; Dorta-Estremera SM
    Cancers (Basel); 2024 May; 16(11):. PubMed ID: 38893183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune cell infiltration patterns and survival in head and neck squamous cell carcinoma.
    Russell S; Angell T; Lechner M; Liebertz D; Correa A; Sinha U; Kokot N; Epstein A
    Head Neck Oncol; 2013 Feb; 5(3):24. PubMed ID: 24723971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Th2 Cells Are Associated with Tumor Recurrence Following Radiation.
    Abdelhakiem MK; Bao R; Pifer PM; Molkentine D; Molkentine J; Hefner A; Beadle B; Heymach JV; Luke JJ; Ferris RL; Pickering CR; Wang JH; Patel RB; Skinner HD
    Cancers (Basel); 2024 Apr; 16(8):. PubMed ID: 38672668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of p16 as a biomarker in nonoropharyngeal head and neck cancer.
    Vitzthum LK; Mell LK
    Oncotarget; 2018 Sep; 9(70):33247-33248. PubMed ID: 30279955
    [No Abstract]   [Full Text] [Related]  

  • 13. Genetic Mutations Associated with Inflammatory Response Caused by HPV Integration in Oropharyngeal Squamous Cell Carcinoma.
    Atique M; Muniz I; Farshadi F; Hier M; Mlynarek A; Macarella M; Maschietto M; Nicolau B; Alaoui-Jamali MA; da Silva SD
    Biomedicines; 2023 Dec; 12(1):. PubMed ID: 38275384
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiomic Characterization Reveals a Distinct Molecular Landscape in Young-Onset Pancreatic Cancer.
    Ogobuiro I; Baca Y; Ribeiro JR; Walker P; Wilson GC; Gulhati P; Marshall JL; Shroff RT; Spetzler D; Oberley MJ; Abbott DE; Kim HJ; Kooby DA; Maithel SK; Ahmad SA; Merchant NB; Xiu J; Hosein PJ; Datta J
    JCO Precis Oncol; 2023 Sep; 7():e2300152. PubMed ID: 37944072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of the Mutation Profile of Tonsillar Squamous Cell Carcinomas Using Targeted Next-Generation Sequencing.
    Park HY; Lee JS; Wee JH; Kang JW; Kim ES; Koo T; Hwang HS; Kim HJ; Kang HS; Lim H; Kim NY; Nam ES; Cho SJ; Kwon MJ
    Biomedicines; 2023 Mar; 11(3):. PubMed ID: 36979829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypermethylation of PRKCZ Regulated by E6 Inhibits Invasion and EMT via Cdc42 in HPV-Related Head and Neck Squamous Cell Carcinoma.
    Wang HF; Jiang J; Wu JS; Zhang M; Pang X; Dai L; Tang YL; Liang XH
    Cancers (Basel); 2022 Aug; 14(17):. PubMed ID: 36077689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An Update on the Immunotherapy for Oropharyngeal Squamous Cell Carcinoma.
    Huang Y; Lan Y; Zhang Z; Xiao X; Huang T
    Front Oncol; 2022; 12():800315. PubMed ID: 35372036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genomic and Molecular Profiling of Human Papillomavirus Associated Head and Neck Squamous Cell Carcinoma Treated with Immune Checkpoint Blockade Compared to Survival Outcomes.
    Shaikh H; McGrath JE; Hughes B; Xiu J; Brodskiy P; Sukari A; Darabi S; Ikpeazu C; Nabhan C; Korn WM; Wise-Draper TM
    Cancers (Basel); 2021 Dec; 13(24):. PubMed ID: 34944929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comprehensive evaluation of human papillomavirus positive status and p16INK4a overexpression as a prognostic biomarker in head and neck squamous cell carcinoma.
    Deng Z; Hasegawa M; Aoki K; Matayoshi S; Kiyuna A; Yamashita Y; Uehara T; Agena S; Maeda H; Xie M; Suzuki M
    Int J Oncol; 2014 Jul; 45(1):67-76. PubMed ID: 24820457
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.